Effect of Gymnema sylvestre Administration on Glycemic Control, Insulin Secretion, and Insulin Sensitivity in Patients with Impaired Glucose Tolerance

다국어 초록 (Multilingual Abstract)

Gymnema sylvestre, a plant typical of India, has long been known for its hypoglycemic effects. The objective of this study was to evaluate the effect of G. sylvestre administration on glycemic control, insulin secretion, and insulin sensitivity in patients with impaired glucose tolerance (IGT). A randomized, double-blind, placebo-controlled clinical trial was conducted in 30 patients with IGT. Fifteen patients randomly received G. sylvestre in doses of 300 mg b.i.d. and the other 15 received placebo in the same way. Before and after the intervention, anthropometric and metabolic measurements were taken, including 2-h oral glucose tolerance test (2-h OGTT), fasting plasma glucose, glycated hemoglobin A1c (A1C), and the lipid profile panel. Areas under the curve of glucose and insulin were calculated, as well as the insulinogenic, Stumvoll, and Matsuda indices. Wilcoxon, Mann–Whitney U, and chi-square or Fisher's exact tests were performed, and a P-value ≤.05 was considered statistically significant. There was a significant reduction in 2-h OGTT (9.1 ± 1.2 vs. 7.8 ± 1.7 mmol/L, P = .003), A1C (5.8 ± 0.3% vs. 5.4 ± 0.4%, P = .025), body weight, body mass index, and low-density lipoprotein cholesterol levels in the G. sylvestre group, with an increment in the Matsuda index (1.8 ± 0.8 vs. 2.4 ± 1.2, P = .008). At the end of the intervention, 46.7% of the patients obtained normal values in A1C. In conclusion, G. sylvestre administration in patients with IGT decreased 2-h OGTT and A1C, increasing insulin sensitivity. There were also improvements in anthropometric measures and the lipid profile.

참고문헌 (Reference)

1 Stumvoll M, "Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity" 23 : 295-301, 2000

2 Shanmugasundaram ER, "Use of Gymnema sylvestre leaf extract in the control of blood glucose in insulin-dependent diabetes mellitus" 30 : 281-294, 1990

3 Kanata M, "Treatment of prediabetes" 6 : 1207-1222, 2015

4 Hostalek U, "Therapeutic use of metformin in prediabetes and diabetes prevention" 75 : 1071-1094, 2015

5 Yeh GY, "Systematic review of herbs and dietary supplements for glycemic control in diabetes" 26 : 1277-1294, 2003

6 Chen G, "Rapid screening for a-glucosidase inhibitors from Gymnema sylvestre by affinity ultrafiltration-hplc-ms" 8 : 1-8, 2017

7 Tiwari P, "Phytochemical and pharmacological properties of Gymnema sylvestre : An important medicinal plant" 2014 : 830285-, 2014

8 Abdul-Ghani MA, "Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test" 30 : 89-94, 2007

9 Jeyaseelan L, "Methods of determining sample sizes in clinical trials" 26 : 115-121, 1989

10 Kimura I, "Medical benefits of using natural compounds and their derivatives having multiple pharmacological actions" 126 : 133-143, 2006

11 Bera R, "In vitro metabolic stability and permeability of gymnemagenin and its in vivo pharmacokinetic correlation in rats—A pilot study" 82 : 544-550, 2016

12 Nathan DM, "Impaired fasting glucose and impaired glucose tolerance : implications for care" 30 : 753-759, 2007

13 Wang Y, "Gymnemic acids inhibit sodium-dependent glucose transporter 1" 62 : 5925-5931, 2014

14 Izutani Y, "Gymnemic acids inhibit rabbit glyceraldehyde-3-phosphate dehydrogenase and induce a smearing of its electrophoretic band and dephosphorylation" 579 : 4333-4336, 2005

15 Kumar V, "Evaluation of antiobesity and cardioprotective effect of Gymnema sylvestre extract in murine model" 44 : 607-, 2012

16 Dalfra` MG, "Elevated insulin sensitivity and b-cell function during pregnancy in mothers of growthrestricted newborns" 301 : E25-E30, 2011

17 Kim HJ, "Effects of feeding a diet containing Gymnema sylvestre extract : Attenuating progression of obesity in C57BL/6J mice" 9 : 437-444, 2016

18 Shigematsu N, "Effect of administration with the extract of Gymnema sylvestre R. Br leaves on lipid metabolism in rats" 24 : 713-717, 2001

19 Bhansali S, "Effect of a deacyl gymnemic acid on glucose homeostasis & metabolic parameters in a rat model of metabolic syndrome" 137 : 1174-1179, 2013

20 El Shafey AAM, "Effect of Gymnema sylvestre R. Br. leaves extract on certain physiological parameters of diabetic rats" 25 : 135-141, 2013

21 Laura Y. Zuniga, "Effect of Gymnema sylvestre Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion" 한국식품영양과학회 20 (20): 750-754, 2017

22 Shane-McWhorter L, "Complementary and Alternative Medicine (CAM) Supplement Use in People with Diabetes: A Clinician’s Guide" American Diabetes Association 7-9, 2007

23 American Diabetes Association, "Classification and diagnosis of diabetes: Standards of medical care in diabetes-2019" 42 (42): S13-S28, 2019

24 Palermo A, "Buzzetti R : Prevention of type 2 diabetes mellitus : Is it feasible" 30 (30): 4-12, 2014

25 Spasov A, "Antidiabetic properties of gymnema sylvestre(a review)" 42 : 626-629, 2008

26 Baskaran K, "Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients" 30 : 295-300, 1990

27 Manish K, "Anti-obesity property of hexane extract from the leaves of Gymnema sylvestre in high fed cafeteria diet induced obesity rats" 2 : 112-116, 2011

28 Porchezhian E, "An overview on the advances of Gymnema sylvestre : Chemistry, pharmacology and patents" 58 : 5-12, 2003

29 Al-Romaiyan A, "A novel extract of Gymnema sylvestre improves glucose tolerance in vivo and stimulates insulin secretion and synthesis in vitro" 27 : 1006-1011, 2013

30 Tai MM, "A mathematical model for the determination of total area under glucose tolerance and other metabolic curves" 17 : 152-154, 1994